MML Investors Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

MML Investors Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15M	Buy	355,711 +212,277	+148%	+$6.76M	0.03%	498
2026 Q1	$3.79M	Buy	143,434 +62,411	+77%	+$1.83M	0.01%	963
2025 Q4	$2.35M	Buy	81,023 +60,893	+302%	+$1.83M	0.01%	1285
2025 Q3	$559K	Sell	20,130 -10,501	-34%	-$265K	﹤0.01%	2097
2025 Q2	$746K	Sell	30,631 -145	-0.5%	-$3.18K	﹤0.01%	1832
2025 Q1	$639K	Sell	30,776 -5,447	-15%	-$137K	﹤0.01%	1847
2024 Q4	$853K	Sell	36,223 -5,578	-13%	-$137K	﹤0.01%	1610
2024 Q3	$1.07M	Sell	41,801 -3,292	-7%	-$83.8K	﹤0.01%	1420
2024 Q2	$1.06M	Sell	45,093 -3,733	-8%	-$94.2K	﹤0.01%	1367
2024 Q1	$1.4M	Sell	48,826 -8,234	-14%	-$248K	0.01%	1226
2023 Q4	$1.87M	Sell	57,060 -15,153	-21%	-$412K	0.01%	1030
2023 Q3	$2.01M	Buy	72,213 +4,961	+7%	+$162K	0.01%	901
2023 Q2	$2.29M	Buy	67,252 +14,865	+28%	+$467K	0.01%	847
2023 Q1	$1.57M	Sell	52,387 -1,483	-3%	-$46K	0.01%	875
2022 Q4	$1.52M	Sell	53,870 -7,076	-12%	-$225K	0.01%	937
2022 Q3	$2M	Sell	60,946 -277	-0.5%	-$10.2K	0.02%	761
2022 Q2	$1.93M	Sell	61,223 -4,368	-7%	-$153K	0.01%	764
2022 Q1	$3.01M	Sell	65,591 -26,824	-29%	-$1.28M	0.02%	639
2021 Q4	$5.66M	Sell	92,415 -35,057	-28%	-$2.42M	0.04%	399
2021 Q3	$9.53M	Buy	127,472 +5,342	+4%	+$448K	0.08%	277
2021 Q2	$11.3M	Buy	122,130 +2,162	+2%	+$184K	0.09%	232
2021 Q1	$10.6M	Buy	119,968 +56,915	+90%	+$5.65M	0.1%	220
2020 Q4	$5.88M	Buy	63,053 +32,187	+104%	+$2.56M	0.06%	288
2020 Q3	$1.97M	Sell	30,866 -5,562	-15%	-$326K	0.02%	526
2020 Q2	$1.9M	Buy	36,428 +7,030	+24%	+$302K	0.03%	520
2020 Q1	$920K	Buy	29,398 +475	+2%	+$15.9K	0.02%	645
2019 Q4	$970K	Buy	28,923 +5,210	+22%	+$166K	0.01%	729
2019 Q3	$700K	Buy	23,713 +2,232	+10%	+$72.5K	0.01%	821
2019 Q2	$740K	Buy	21,481 +1,215	+6%	+$38.9K	0.01%	850
2019 Q1	$666K	Buy	20,266 +1,763	+10%	+$52.1K	0.01%	875
2018 Q4	$444K	Buy	18,503 +3,657	+25%	+$103K	0.01%	967
2018 Q3	$496K	Buy	14,846 +4,171	+39%	+$132K	0.01%	1002
2018 Q2	$310K	Buy	+10,675	New	+$297K	0.01%	1064

Other funds holding ARKG

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM

CIC

Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CFIM

Client First Investment Management West Bend, Wisconsin $237M AUM 90.26% 1-Year Est. Return

MML Investors Services's ARKG Position: Q2 2026 in Review

MML Investors Services increased its ARK Genomic Revolution ETF (ARKG) stake by 148% in Q2 2026, buying an estimated $6.76M and bringing the position to 355,711 shares worth $15M. The position accounts for 0.03% of the portfolio, ranked #498.

MML Investors Services first reported a position in ARKG in Q2 2018 and has held it in 33 quarters since. 157 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

MML Investors Services held 355,711 shares of ARK Genomic Revolution ETF worth $15M as of Q2 2026.
MML Investors Services bought 212,277 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $6.76M.
ARK Genomic Revolution ETF made up 0.03% of MML Investors Services's portfolio in Q2 2026, its #498 holding.
MML Investors Services first reported a position in ARK Genomic Revolution ETF in Q2 2018 and has held it in 33 quarters since.
157 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.